ESR1 and breast cancer: BC is a heterogeneous disease that can be divided into multiple molecular subtypes based on estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) expression, providing important prognostic and predictive information [3].